[
  {
    "ts": null,
    "headline": "Pfizer (PFE) CEO’s Struggling Because Of “a Good Hand,” Says Jim Cramer",
    "summary": "We recently published 12 Stocks on Jim Cramer’s Radar. Pfizer Inc. (NYSE:PFE) is one of the stocks on Jim Cramer’s radar. Pfizer Inc. (NYSE:PFE)’s shares are down by 5.90% year-to-date, and December has been a tumultuous month for them. On Tuesday, the stock dipped by 5.2% after the firm released its full-year 2026 guidance. The […]",
    "url": "https://finnhub.io/api/news?id=1e6b776ab089aceac7976de11e670f1bef3c13f293c0b3a2da9172f50c43dc5e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1766155875,
      "headline": "Pfizer (PFE) CEO’s Struggling Because Of “a Good Hand,” Says Jim Cramer",
      "id": 137831600,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "We recently published 12 Stocks on Jim Cramer’s Radar. Pfizer Inc. (NYSE:PFE) is one of the stocks on Jim Cramer’s radar. Pfizer Inc. (NYSE:PFE)’s shares are down by 5.90% year-to-date, and December has been a tumultuous month for them. On Tuesday, the stock dipped by 5.2% after the firm released its full-year 2026 guidance. The […]",
      "url": "https://finnhub.io/api/news?id=1e6b776ab089aceac7976de11e670f1bef3c13f293c0b3a2da9172f50c43dc5e"
    }
  },
  {
    "ts": null,
    "headline": "Jim Cramer Couldn’t Stop Gushing About Johnson & Johnson (JNJ)’s Cancer Drugs",
    "summary": "We recently published 12 Stocks on Jim Cramer’s Radar. Johnson & Johnson (NYSE:JNJ) is one of the stocks on Jim Cramer’s radar. Healthcare giant Johnson & Johnson (NYSE:JNJ) factored into the discussion after Cramer and his co-hosts discussed Pfizer and Merck. The firm’s shares are up by 46% year-to-date and have had a good December […]",
    "url": "https://finnhub.io/api/news?id=040daca37b58183a1104f78ad75b13f4500d449d6715763434e12cc62efb32ae",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1766155822,
      "headline": "Jim Cramer Couldn’t Stop Gushing About Johnson & Johnson (JNJ)’s Cancer Drugs",
      "id": 137831377,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "We recently published 12 Stocks on Jim Cramer’s Radar. Johnson & Johnson (NYSE:JNJ) is one of the stocks on Jim Cramer’s radar. Healthcare giant Johnson & Johnson (NYSE:JNJ) factored into the discussion after Cramer and his co-hosts discussed Pfizer and Merck. The firm’s shares are up by 46% year-to-date and have had a good December […]",
      "url": "https://finnhub.io/api/news?id=040daca37b58183a1104f78ad75b13f4500d449d6715763434e12cc62efb32ae"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer Isn't Dead Money, Pipeline Execution Can Spark A Rebound",
    "summary": "Discover why Pfizer (PFE) remains a compelling income opportunity with a 7% yield, robust cash flow, and long-term growth prospects.",
    "url": "https://finnhub.io/api/news?id=1fc6954484b6f9b76158e2e30007b5000f40736585b6cd2dcdc1ad93fa7c1748",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1766144700,
      "headline": "Pfizer Isn't Dead Money, Pipeline Execution Can Spark A Rebound",
      "id": 137832713,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1292440985/image_1292440985.jpg?io=getty-c-w1536",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "Discover why Pfizer (PFE) remains a compelling income opportunity with a 7% yield, robust cash flow, and long-term growth prospects.",
      "url": "https://finnhub.io/api/news?id=1fc6954484b6f9b76158e2e30007b5000f40736585b6cd2dcdc1ad93fa7c1748"
    }
  },
  {
    "ts": null,
    "headline": "Down 80%, Should You Buy the Dip on Moderna?",
    "summary": "Your decision on whether to invest now depends to some extent on your investment strategy.",
    "url": "https://finnhub.io/api/news?id=2d824e62d6ae5140040d790d965c4fb9e7f0c56e568928e32d43620795210685",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1766136600,
      "headline": "Down 80%, Should You Buy the Dip on Moderna?",
      "id": 137831602,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Your decision on whether to invest now depends to some extent on your investment strategy.",
      "url": "https://finnhub.io/api/news?id=2d824e62d6ae5140040d790d965c4fb9e7f0c56e568928e32d43620795210685"
    }
  },
  {
    "ts": null,
    "headline": "Dividend Harvesting Portfolio Week 250: $25,000 Allocated, $2,646.53 In Projected Dividends",
    "summary": "Discover how the Dividend Harvesting Portfolio yields 8.09%, with Chevron added for growth amid Fed rate cuts.",
    "url": "https://finnhub.io/api/news?id=7412adbb65ea4bc6a090e8e27588f96300f008ea013fa045a47bb4e1b0875269",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1766133900,
      "headline": "Dividend Harvesting Portfolio Week 250: $25,000 Allocated, $2,646.53 In Projected Dividends",
      "id": 137830796,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1445810162/image_1445810162.jpg?io=getty-c-w1536",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "Discover how the Dividend Harvesting Portfolio yields 8.09%, with Chevron added for growth amid Fed rate cuts.",
      "url": "https://finnhub.io/api/news?id=7412adbb65ea4bc6a090e8e27588f96300f008ea013fa045a47bb4e1b0875269"
    }
  },
  {
    "ts": null,
    "headline": "Wall Street banked on a flurry of deals under Trump in 2025. It wasn't that simple",
    "summary": "Dealmakers expected a flood of M&A to take place in 2025 following the election of President Trump. The number of transactions didn't live up to the hype.",
    "url": "https://finnhub.io/api/news?id=83718e67a6b973deccc8adf1b882bd7df6874319d055b3f61efb5fb03ac72739",
    "source": "CNBC",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1766129402,
      "headline": "Wall Street banked on a flurry of deals under Trump in 2025. It wasn't that simple",
      "id": 137833066,
      "image": "https://image.cnbcfm.com/api/v1/image/108070888-1733274802301-gettyimages-1229038380-mcgrego_snowstorm111618_22.jpeg?v=1766078954&w=1920&h=1080",
      "related": "PFE",
      "source": "CNBC",
      "summary": "Dealmakers expected a flood of M&A to take place in 2025 following the election of President Trump. The number of transactions didn't live up to the hype. ",
      "url": "https://finnhub.io/api/news?id=83718e67a6b973deccc8adf1b882bd7df6874319d055b3f61efb5fb03ac72739"
    }
  },
  {
    "ts": null,
    "headline": "1 S&P 500 Stock with Impressive Fundamentals and 2 That Underwhelm",
    "summary": "While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural headwinds.",
    "url": "https://finnhub.io/api/news?id=167aaab6a3f3b4748c94b3843f4f2d57e263e6d8a8b8cb64e57282822ed5785f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1766118834,
      "headline": "1 S&P 500 Stock with Impressive Fundamentals and 2 That Underwhelm",
      "id": 137831302,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural headwinds.",
      "url": "https://finnhub.io/api/news?id=167aaab6a3f3b4748c94b3843f4f2d57e263e6d8a8b8cb64e57282822ed5785f"
    }
  },
  {
    "ts": null,
    "headline": "3 Absurdly Cheap Stocks You Can Buy For Less than $100 Right Now",
    "summary": "The stocks listed here trade at forward earnings multiples of less than 18.",
    "url": "https://finnhub.io/api/news?id=0b2833b73670249dd922f945b95316a449c5e2c1835da8206c6279b5f36b5f55",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1766109000,
      "headline": "3 Absurdly Cheap Stocks You Can Buy For Less than $100 Right Now",
      "id": 137831604,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "The stocks listed here trade at forward earnings multiples of less than 18.",
      "url": "https://finnhub.io/api/news?id=0b2833b73670249dd922f945b95316a449c5e2c1835da8206c6279b5f36b5f55"
    }
  }
]